The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

Merck (MRK) stock in focus as the FDA approves its anticancer agent Welireg for two rare neuroendocrine tumors, expanding its ...

The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

National Security Division (NSD) announced its second-ever public declination under its updated corporate voluntary self-disclosure (VSD) policy when it declined to charge Universities Space Research ...

Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...

Investing.com -- Citi downgraded both AbbVie (NYSE: ABBV) and Merck (NSE: PROR) to Neutral in separate notes Wednesday, ...

On May 12th the president signed an executive order that seeks to force drugmakers to reduce their prices in America to align ...

IO Biotech was named to Fast Company's World's Most Innovative Companies of 2025 list for its potentially game-changing approach to immune-modulatory cancer vaccines, earning its place on the coveted ...

Food allergy in children with atopic dermatitis is associated with an increased risk for asthma, allergic rhinitis, and ...

"I must say it's always impressive to come back to China and witness its significant and rapid transformation happening over ...